Short Interest in Jounce Therapeutics, Inc. (NASDAQ:JNCE) De

Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,020,000 shares, a drop of 11.4% from the March 31st total of 2,280,000 shares. Based on an average trading volume of 2,640,000 shares, the days-to-cover ratio is […]

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Louism Weiner , Padmanee Sharma , Piper Sandler , Raymond James , Jamesp Allison , Robert Schreiber , Kevinc Tang , Thomasf Gajewski , Health Sciences , Virtu Financial , Susquehanna International Group , Capital Management , Moloney Securities Asset Management , Nasdaq , Jounce Therapeutics Inc , Sumitomo Mitsui Financial Group , Securities Exchange Commission , Jounce Therapeutics , Get Rating , Exchange Commission , Director Richard , International Group , Securities Asset Management , Mitsui Financial Group , Jounce Therapeutics Daily , Nasdaq Jnce , Jnce , Medical , Stocks , Options , Put , Call ,